IDEAYA Biosciences, Inc. Common Stock
IDYA
$31.48
+11.28%
IDYA
IDEAYA Biosciences, Inc. Common Stock
$31.48
IDYA price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IDEAYA Biosciences, Inc. Common Stock's 12-month outlook, with a consensus price target around $40.92 and implied upside of +30.0% versus the current price.
Average Target
$40.92
13 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$25 - $41
Analyst target range
IDYA Technical Analysis
Beta
-0.05
-0.05x market volatility
Max Drawdown
-26.4%
Largest decline past year
52-Week Range
$20-$39
Price range past year
Annual Return
+44.9%
Cumulative gain past year
| Period | IDYA Return | S&P 500 |
|---|---|---|
| 1m | +11.2% | +0.2% |
| 3m | -9.4% | +9.2% |
| 6m | -6.4% | +7.5% |
| 1y | +44.9% | +23.4% |
| ytd | -7.0% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is IDYA Overvalued?
PE
-26.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-19.2x
Enterprise Value Multiple